We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Glycolysis Produces the Power for Sperm Motility

By Biotechdaily staff writers
Posted on 06 Dec 2004
Researchers studying male infertility have found that the enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPD), a key component of the glycolysis pathway, is required to produce the energy needed by sperm cells to migrate towards the awaiting eggs.

Investigators at the University of North Carolina Medical School (Chapel Hill, NC, USA) genetically engineered a line of mice lacking the gene for GAPDS, the form of the enzyme found in mouse sperm cells. More...
They reported in the November 16, 2004, online edition of the Proceedings of the [U.S.] National Academy of Sciences that while these animals mated normally with receptive female mice, they were infertile. Examination of their sperm under the microscope revealed that the sperm showed only a slight side-to-side movement, but were incapable of moving forward.

At the biochemical level it was found that although mitochondrial oxygen consumption was unchanged, sperm from these mice had adenosine triphosphate (ATP) levels that were only 10.4% of those in sperm from control mice. Thus, most of the energy required for sperm motility was generated by glycolysis rather than oxidative phosphorylation.

"We were very surprised at this finding,” said senior author Dr. Deborah O'Brien, associate professor of cell and developmental biology at the University of North Carolina School of Medicine. "It turned out that almost all of the sperm's motility and ATP production depended on this enzyme.”

Since a form of GAPD is present in human sperm, the authors suggested that it might be a good target for contraceptive agents, and that environmental agents that affect its activity may be related to male infertility in humans.




Related Links:
North Carolina School of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Electrolyte Analyzer
BKE-B
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image: The LymphoTrack Flex suite is an integrated next-generation sequencing solution for identifying and tracking immunoglobulin and T-cell receptor gene rearrangements (Photo courtesy of Invivoscribe)

New NGS Suite Expands Clonality and MRD Research in Lymphoid Malignancies

Lymphoid malignancies require molecular tools that can distinguish clonal immune receptor rearrangements and track disease-related sequences over time. As immune receptor measurable residual disease analysis... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.